Overall Technical outlook

Price Summary

On 2025-06-12, Gland Pharma Limited's stock started at 1682.0, soared to 1699.2, dropped to 1646.1, and finished the day -0.75% lower at 1669.4, with a trading volume of 109120 shares.
Over the past 52 weeks, the stock reached a maximum price of 2141.6 and a minimum price of 1392.8.
The expected price range is between 1162.0 and 3120.0, with a mean anticipated price of 1677.6666, according to 12 analysts.

Technicals

Support and Resistance: With the current price at 1669.4, support is found at 1617.8 and resistance at 1747.4. These levels indicate where buyers might step in at 1617.8, while sellers could limit gains at 1747.4, defining a trading boundary for Gland Pharma Limited.
GLAND supportResistance 233a1d
Support/Resistance for GLAND


Aroon: The AROON is currently neutral, offering no clear guidance on market direction. This suggests that the market may be in a state of pause, with no strong trend emerging.
GLAND aroon 233a1d
Aroon chart for Gland Pharma Limited


Bol. Bands: The BOLL BANDS is in a neutral stance, with no clear direction indicated for the market. This lack of clarity suggests that the market may be in a state of equilibrium for GLAND, with no strong trend emerging.
GLAND bbands 233a1d
Bolinger Bands chart for Gland Pharma Limited


Parabolic SAR: The PSAR continues its bullish outlook, reinforcing a crucial support level that may help sustain the current upward trend. This support suggests that the market is likely to continue climbing, with the bullish momentum remaining strong.
GLAND psar 233a1d
Parabolic Stop and Reverse chart for Gland Pharma Limited


Stochastic: The stochastic indicator reflects the K-line falling below the D-line, though it remains above 80, hinting at the possible start of a bearish price move. This suggests that the market may be losing its recent strength, with a potential decline ahead. Traders should be on the lookout for further evidence of a bearish trend for Gland Pharma Limited.
GLAND stoch 233a1d
Stochastic chart for Gland Pharma Limited


Tripple Moving Agerage: The current reading of the Tripple MOVING AVG indicator suggests a neutral stance, with no clear signals indicating an upward or downward direction. This lack of directional bias suggests the market may be in a period of consolidation or uncertainty.
GLAND trippleSMA 233a1d
Tripple SMA chart for Gland Pharma Limited


To properly assess the technical data of a company, it's important to first look at its fundamentals, such as its earnings, growth potential, and management effectiveness. Equally, understanding the industry trends, competition, and external economic factors that influence the company is vital. This holistic view helps draw meaningful conclusions about the company's technical performance, allowing investors to better gauge its stock price behavior, volatility, and market trends.